Comparative Analysis of Acid Sphingomyelinase Distribution in the CNS of Rats and Mice Following Intracerebroventricular Delivery
Author Information
Author(s): Treleaven Christopher M., Tamsett Thomas, Fidler Jonathan A., Taksir Tatyana V., Cheng Seng H., Shihabuddin Lamya S., Dodge James C.
Primary Institution: Genzyme Corporation
Hypothesis
Can intracerebroventricular delivery of human acid sphingomyelinase (hASM) achieve widespread enzyme distribution in the rat CNS similar to that observed in ASM knockout mice?
Conclusion
Intracerebroventricular infusion of hASM leads to widespread enzyme delivery throughout the CNS in rats, but only a small percentage of the total dose reaches the CNS tissue.
Supporting Evidence
- ICV infusion of hASM resulted in significant enzyme distribution throughout the CNS.
- Less than 1% of the total dose administered was detected in CNS tissue.
- Significant levels of hASM were detected in serum following ICV infusion.
- Similar levels of hASM were achieved in rats and mice when doses were normalized to CNS weight.
Takeaway
The study shows that giving a special enzyme directly into the brain can help spread it throughout the brain and spine, but only a tiny bit of the enzyme actually gets there.
Methodology
Female Sprague Dawley rats were infused with hASM or artificial cerebrospinal fluid, followed by analysis of enzyme distribution using immunohistochemistry and ELISA.
Potential Biases
Potential bias due to funding and employment of authors by Genzyme Corporation.
Limitations
The study primarily focuses on rats and may not fully translate to larger animal models or humans.
Participant Demographics
Female Sprague Dawley rats aged 8 to 10 weeks.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website